高级检索
当前位置: 首页 > 详情页

Pin1 impairs microRNA biogenesis by mediating conformation change of XPO5 in hepatocellular carcinoma.

文献详情

资源类型:
Pubmed体系:
机构: [1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu 610041, China [2]Department of Chemistry and Institute for Biophysical Dynamics Howard Hughes Medical Institute, The University of Chicago, Chicago, IL 60637, USA [3]College of Life Sciences, Sichuan University, Chengdu 610041, China [4]Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
出处:
ISSN:

摘要:
MicroRNA (miRNA) dysregulation is associated with the tumorigenesis and development of numerous human cancers. The defect in miRNA biogenesis is the main cause of miRNA dysregulation. We previously demonstrated that ERK-induced phosphorylation of XPO5 followed by peptidyl-prolyl cis/trans isomerase Pin1-mediated isomerization downregulates miRNA expression and contributes to hepatocellular carcinoma (HCC) development. However, how Pin1 precisely regulates miRNA biogenesis in HCC remains elusive. Here we reveal that Pin1 has a pivotal role in the miRNA maturation process by modulating phosphorylated Serine-Proline (pS-P) motif of XPO5 in a phosphorylation-dependent manner. By recognizing and binding to XPO5 via its WW domain, Pin1 catalyzes the conformation change of XPO5 and diminishes XPO5 ability to export pre-miRNAs from the nucleus to the cytoplasm, resulting in the reduced mature miRNA levels and promoted HCC development. Furthermore, downregulation of Pin1 by shRNA restores XPO5-dependent pre-miRNA export and effective biogenesis of mature miRNAs, leading to both in vitro and in vivo HCC inhibition. Therefore, our research discloses a new posttranscriptional regulatory mechanism of miRNA biosynthesis and provides the experimental basis for a novel HCC therapy by targeting Pin1.

基金:
语种:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 1 区 生物
小类 | 2 区 生化与分子生物学 2 区 细胞生物学
最新[2023]版:
大类 | 1 区 生物学
小类 | 1 区 生化与分子生物学 2 区 细胞生物学
第一作者:
第一作者机构: [1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu 610041, China
共同第一作者:
通讯作者:
通讯机构: [1]State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University and Collaborative Innovation Center of Biotherapy, Chengdu 610041, China [4]Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu 610041, China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:46441 今日访问量:0 总访问量:3323 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 四川省肿瘤医院 技术支持:重庆聚合科技有限公司 地址:成都市人民南路四段55号